Ashkan Emadi, MD
Hematology & Oncology · Morgantown, WVNPI 1457562753
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $80,247 of the $88,241 with a category attached, or 90.9%. 12 manufacturers reported payments, led by Secura Bio, Inc. at 30.1% of the total. Reporting peaked in 2021 at $29,715 and has fallen 82.8% since, to $5,103 in 2025. Among hematology & oncology clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 79 payments — averaging $1116.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Secura Bio, Inc.$27K
- Amgen$22K
- Gilead$16K
- Servier Pharmaceuticals LLC$9K
- Merck$6K
- Genentech USA, Inc.$5K
- plus $4K from 6 others
Across 286 payments — averaging $30,073 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$6.4M
- Servier Bioinnovation$1.3M
- Jazz Pharmaceuticals Inc.$479K
- Macrogenics, Inc.$213K
- Institut DE Recherches Servier$146K
- Agios Pharmaceuticals, Inc.$55K
What the payments were for
- Consulting fees$80,24791%
- Speaking & faculty fees$1,0001%
- Travel & lodging$4,3575%
- Food & beverage$2,6383%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Secura Bio, Inc. | 6 | $26,565 |
| Amgen | 14 | $21,597 |
| Gilead | 6 | $15,950 |
| Servier Pharmaceuticals LLC | 22 | $9,201 |
| Merck | 18 | $6,074 |
| Genentech USA, Inc. | 5 | $4,506 |
| Incyte Corporation | 1 | $2,818 |
| Bristol Myers Squibb | 1 | $1,000 |
| Jazz Pharmaceuticals Inc. | 3 | $369 |
| Novartis | 1 | $104 |
| AstraZeneca | 1 | $35 |
| Daiichi Sankyo Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$88,241 in reported general payments places this provider in the 95th percentile of 72 hematology & oncology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SprycelDasatinib | 13 | $224,216 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Morgantown
- Abraham KanateMorgantown$169K
- Konstantinos SdrimasMorgantown$81K
- Ihtishaam QaziMorgantown$18K
- Sonikpreet AulakhMorgantown$17K
- Salah Ud Din SafiMorgantown$5K
- Michael CraigMorgantown$5K
- Joanna KolodneyMorgantown$3K
- Amir KamranMorgantown$2K
- Sobha KurianMorgantown$1K
- Pooja Gogia BhasinMorgantown$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.